Spots Global Cancer Trial Database for adenocarcinoma of the rectum
Every month we try and update this database with for adenocarcinoma of the rectum cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | NCT00062426 | Colorectal Canc... | bevacizumab capecitabine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00080951 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00004870 | Colorectal Canc... | oblimersen sodi... irinotecan hydr... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | NCT00002551 | Colorectal Canc... | fluorouracil leucovorin calc... levamisole hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer | NCT00006103 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... | - | Alliance for Clinical Trials in Oncology | |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | NCT00084591 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00296608 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 75 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer | NCT00462501 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin conventional su... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00006001 | Colorectal Canc... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | NCT00026273 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 75 Years | Pfizer | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab | NCT04554836 | Adenocarcinoma ... Adenocarcinoma ... | Cetuximab FOLFIRI | 18 Years - 99 Years | TheraOp | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer | NCT00899210 | Colorectal Canc... Metastatic Canc... | laboratory biom... cryosurgery radiofrequency ... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer | NCT03053544 | Rectal Neoplasm... | Metformin | 19 Years - | Sunnybrook Health Sciences Centre | |
| BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | NCT00022477 | Colorectal Canc... | BMS-247550 | 18 Years - | University of Chicago | |
| Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | NCT00075595 | Colorectal Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | NCT00081289 | Colorectal Canc... | Radiation Thera... Capecitabine 16... Capecitabine 12... Irinotecan Oxaliplatin Surgery Folinic Acid Fluorouracil Oxaliplatin | 18 Years - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery | NCT00513266 | Colorectal Canc... Metastatic Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Genetic Study of Young Patients With Colorectal Cancer | NCT00044967 | Colorectal Canc... | microsatellite ... | 18 Years - 49 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | NCT00002523 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer | NCT00686166 | Colorectal Canc... | cetuximab capecitabine oxaliplatin therapeutic sur... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | NCT01189227 | Colorectal Canc... Metastatic Canc... | Postoperative c... Perioperative c... | 18 Years - | NSABP Foundation Inc | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT00628810 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | NCT00707889 | Advanced Colore... Adenocarcinoma ... Adenocarcinoma ... | ABT-869 bevacizumab oxaliplatin folinic acid fluorouracil ABT-869 | 18 Years - | AbbVie | |
| Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00296608 | Colorectal Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 75 Years | Federation Francophone de Cancerologie Digestive | |
| BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | NCT00033306 | Colorectal Canc... | ixabepilone Fluoropyrimidin... Irinotecan | 18 Years - | University of Alabama at Birmingham | |
| External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer | NCT00869570 | Colorectal Canc... | capecitabine sorafenib tosyl... radiation thera... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | NCT00100841 | Adenocarcinoma ... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | cetuximab bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Proton Therapy With Capecitabine for Rectal Cancer | NCT00503932 | Rectal Cancer | Proton Therapy Capecitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits | NCT03303547 | Adenocarcinoma ... | MRI mapping to ... | 16 Years - | Imperial College London | |
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | NCT00062348 | Colorectal Canc... Head and Neck C... Metastatic Canc... | boronophenylala... sodium borocapt... conventional su... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00004870 | Colorectal Canc... | oblimersen sodi... irinotecan hydr... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | NCT00433576 | Adenocarcinoma ... Adenocarcinoma ... Stage I Colon C... Stage I Rectal ... Stage II Colon ... Stage II Rectal... Stage III Colon... Stage III Recta... | resveratrol pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | NCT00003422 | Colorectal Canc... | fluorouracil leucovorin calc... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 75 Years | National Cancer Institute (NCI) | |
| Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer | NCT00028626 | Colorectal Canc... Metastatic Canc... | embolization th... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | NCT00003220 | Colorectal Canc... | bryostatin 1 | - | Barbara Ann Karmanos Cancer Institute | |
| Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00098787 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... Oxaliplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer | NCT00408772 | Colorectal Canc... Metastatic Canc... | bevacizumab capecitabine oxaliplatin conventional su... neoadjuvant the... radiofrequency ... | 18 Years - 120 Years | University of California, Davis | |
| Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00003594 | Colorectal Canc... | irinotecan fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer | NCT00056030 | Colorectal Canc... Metastatic Canc... | cetuximab fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | NCT00081289 | Colorectal Canc... | Radiation Thera... Capecitabine 16... Capecitabine 12... Irinotecan Oxaliplatin Surgery Folinic Acid Fluorouracil Oxaliplatin | 18 Years - | Radiation Therapy Oncology Group | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum | NCT00081224 | Colorectal Canc... | capecitabine celecoxib radiation thera... surgery | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer | NCT00077259 | Colorectal Canc... | epothilone D | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | NCT00080834 | Colorectal Canc... | DJ-927 | 18 Years - | Daiichi Sankyo | |
| Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery | NCT00936832 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... laboratory biom... pharmacogenomic... pharmacological... | 18 Years - 120 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | NCT00268398 | Colorectal Canc... Metastatic Canc... Chemotherapy | oxaliplatin, fo... oxaliplatin, ir... | 18 Years - 75 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer | NCT00003753 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine irinotecan hydr... adjuvant therap... conventional su... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | NCT00280176 | Colorectal Canc... | bortezomib fluorouracil radiation thera... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT00467142 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... polymorphism an... | 18 Years - 120 Years | Institut Bergonié | |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00052559 | Adenocarcinoma ... Stage II Rectal... Stage III Recta... | bevacizumab fluorouracil external beam r... therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer | NCT00602329 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | NCT00002893 | Colorectal Canc... | fluorouracil leucovorin calc... raltitrexed | - | National Cancer Institute (NCI) | |
| Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | NCT00098787 | Colorectal Canc... | bevacizumab fluorouracil irinotecan hydr... leucovorin calc... Oxaliplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer | NCT00002997 | Colorectal Canc... Metastatic Canc... | cryosurgery | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy | NCT01099449 | Chemotherapeuti... Colorectal Canc... Neuropathy Neurotoxicity | calcium glucona... magnesium sulfa... placebo oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | NCT00005085 | Colorectal Canc... | becatecarin | 18 Years - | National Cancer Institute (NCI) | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00972881 | Rectal Cancer | cetuximab capecitabine irinotecan hydr... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | University College, London | |
| G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | NCT00541125 | Colorectal Canc... | bevacizumab filgrastim fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 74 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | NCT00016978 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
